TFF Pharmaceuticals Inc (TFFP)
0.3761
-1.22
(-76.49%)
USD |
NASDAQ |
Nov 15, 16:00
0.3651
-0.01
(-2.92%)
After-Hours: 20:00
TFF Pharmaceuticals Max Drawdown (5Y): 99.72% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 99.72% |
| September 30, 2024 | 99.72% |
| August 31, 2024 | 99.72% |
| July 31, 2024 | 99.68% |
| June 30, 2024 | 99.68% |
| May 31, 2024 | 99.63% |
| April 30, 2024 | 99.48% |
| March 31, 2024 | 99.03% |
| February 29, 2024 | 99.03% |
| January 31, 2024 | 99.03% |
| December 31, 2023 | 98.89% |
| November 30, 2023 | 98.89% |
| October 31, 2023 | 98.59% |
| September 30, 2023 | 98.42% |
| August 31, 2023 | 98.35% |
| July 31, 2023 | 98.35% |
| June 30, 2023 | 97.81% |
| May 31, 2023 | 97.67% |
| April 30, 2023 | 97.22% |
| March 31, 2023 | 96.86% |
| February 28, 2023 | 96.86% |
| January 31, 2023 | 95.75% |
| December 31, 2022 | 95.75% |
| November 30, 2022 | 94.08% |
| October 31, 2022 | 87.34% |
| Date | Value |
|---|---|
| September 30, 2022 | 79.80% |
| August 31, 2022 | 79.80% |
| July 31, 2022 | 79.80% |
| June 30, 2022 | 79.80% |
| May 31, 2022 | 79.80% |
| April 30, 2022 | 74.63% |
| March 31, 2022 | 73.27% |
| February 28, 2022 | 73.27% |
| January 31, 2022 | 73.06% |
| December 31, 2021 | 65.27% |
| November 30, 2021 | 64.76% |
| October 31, 2021 | 64.51% |
| September 30, 2021 | 63.49% |
| August 31, 2021 | 61.67% |
| July 31, 2021 | 58.03% |
| June 30, 2021 | 57.06% |
| May 31, 2021 | 57.06% |
| April 30, 2021 | 43.54% |
| March 31, 2021 | 35.00% |
| February 28, 2021 | 35.00% |
| January 31, 2021 | 35.00% |
| December 31, 2020 | 35.00% |
| November 30, 2020 | 35.00% |
| October 31, 2020 | 35.00% |
| September 30, 2020 | 35.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
7.22%
Minimum
Nov 2019
99.72%
Maximum
Aug 2024
69.58%
Average
77.22%
Median
Max Drawdown (5Y) Benchmarks
| Eyenovia Inc | 94.04% |
| NovaBay Pharmaceuticals Inc | 99.98% |
| Palatin Technologies Inc | 97.38% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |